Square Announces Official Launch in Spain After Successful Early Access Programme
25.1.2022 13:30:00 EET | Business Wire | Press release
Square, the company specialising in software, payments, and hardware solutions for businesses of all sizes, announces its arrival in Spain following a successful Early Access Programme. Starting today, Spanish entrepreneurs, freelancers and business owners will be able to use Square's ecosystem of tools; the only end-to-end solution of its kind in the country.
"We’ve been trialing Square’s suite of products both in-store and online and we love it,” said Miguel Gil, owner of Hop Hop Hurrah , one of the first businesses to use Square’s products in Spain. “Having a point-of-sale system with integrated payments and omnichannel solutions has transformed the way we’re able to run our business, making it an easy and seamless process. We’re pleased we were able to switch to Square and feel much more confident in our ability to grow, ensuring we never miss a sale, as we look towards the future.”
Square is part of Block, Inc. a global technology company focused on financial services, founded in 2009 and headquartered in San Francisco. Square is currently present in nine countries, with Spain being the fourth European country and the first launched in 2022, after landing in Ireland and France last year and the UK in 2017. Square seeks to help entrepreneurs in a country where SMEs account for 99% of businesses, so that they can easily sell their products and services, both in physical shops and online, as their needs evolve. Square will also be rolling out support in Catalan over the coming months.
“We are thrilled to expand Square’s solutions into Spain, helping merchants to run their entire business end-to-end with integrated software, hardware and data analytics, while making it easy for them to take card payments,” said Alyssa Henry, Head of Square. “Spanish businesses of all types and sizes will now be able to use our integrated ecosystem of products and services to grow, adapt, and run their businesses.”
Xiana Méndez, Secretary of State for Trade commented: “For a quick economic recovery, SMEs and fintech industry must go hand in hand. SMEs must evolve at the same speed as the market and thanks to fintech they can do so in an easy, swift and convenient way. The technology provided by these technological financial firms guarantees them innovative solutions in terms of payment management that can be decisive in supporting their growth. In Spain, Square will find a very thriving market!”
Integrated solutions for multiple business needs
With a suite of products that fully integrate with each other, Square offers one-stop solutions for a variety of business needs: from creating an online shop, accepting physical and online card payments, or managing a retailer's inventory; to keeping a busy restaurant kitchen under control, scheduling appointments, invoicing clients, managing employees, and selling electronic gift cards, among many other time-saving services for businesses.
Square's full offer in Spain includes:
-
Point of sale and payments software and hardware to suit any business: Square launches with three point of sale (POS) software products and three versatile payment terminals, offering both mobile and brick & mortar businesses fully integrated POS software, reliable and secure payments acceptance, and one transparent processing rate. With no long-term commitments or subscription fees, the systems are designed for businesses and their employees to get started quickly.
- Square Point of Sale is the trusted solution used by business owners around the world to process payments, sell anywhere, and manage their customer base. With fast checkout flows, built-in customer management, and intuitive sales reporting, Square Point of Sale makes it easy to run a business customers love.
- Square for Restaurants harnesses its POS expertise with an industry-specific integrated set of tools for food and beverage merchants that would ordinarily require multiple vendors, all under one umbrella.
- Square Appointments is an all-in-one POS for booking, payments, team management, and more. It’s built for beauty, personal care, and wellness sellers who benefit from online scheduling, automatic reminders, and payment processing to run everything easily from one place.
- Square Register, Square Terminal, and Square Reader are versatile, easy-to-set-up devices. For a limited time, new Square sellers will be able to buy their first unit at a reduced price: Square Register will be priced at 299 € (usually 599 €), Square Terminal will be 99 € (usually 165 €), and Square Reader will be completely free (usually 19 €) – all available on Square Shop.
-
eCommerce and online payments: No matter what you sell, Square makes it easy to start selling it online.
- Square Online is Square’s fully integrated e-commerce platform that automatically syncs inventory and orders with any Square point of sale. Square Online supports sellers across a variety of verticals: from easily enabling click-and-collect for local business, to a QR code ordering platform allowing diners to order and pay from their mobile device, to a full ecommerce website with social media integrations for retail. Square Online offers a feature-rich free plan (just pay for processing when you make a sale) as well as a variety of paid subscription plans and payment processing is competitively priced..
- Online Checkout to quickly sell online via embeddable buy buttons and payment links.
- Virtual Terminal to use a computer to take payments remotely.
- Square Invoices to help businesses send professional, digital estimates and invoices and get paid faster.
- E-Gift cards that can be sold online and in-store, to help boost sales and attract new customers.
-
Robust business tools to power operations: Square manages the behind-the-scenes details, giving time back to merchants to focus on running their business. Tools include:
- Team Management, to streamline timecards and staffing.
- Kitchen Display System (Square KDS), to expedite kitchen operations – including managing delivery orders.
- App Marketplace with seamlessly integrated apps to unlock even more functionality: Square integrates with ecommerce tools like PrestaShop, WooCommerce, Wix and Ecwid, as well as accounting platforms Quaderno and CommerceSync, and ordering platforms such as Deliverect.
- Suite of API’s enabling developers to create solutions for sellers: Our APIs and SDKs enable developers to build custom applications that can seamlessly integrate with the rest of our ecosystem of products.
An Early Access Programme with applications from a broad range of industries
The company's Early Access Programme, which started in September 2021 with limited places for beta testers, saw registrations from companies and self-employed people across multiple sectors including restaurants and hospitality, professional services, beauty, retail as well as health and wellness. Some of the Spanish establishments that have already been able to enjoy Square's services in advance are Pastelería Tallón, Valentine and Hop Hop Hurrah.
“At Square, our growth is directly tied to our customers’ growth - when they succeed, we succeed,” says Jason Lalor, European Executive Director at Square. “Our Early Access Programme has been very well received by Spanish business owners and now, with the official launch, we’re excited to partner with all types of businesses across Spain and continue to help them grow.”
Square products and services are available in Spain starting today. To learn more about getting started with Square, visit https://squareup.com/es/es
*This pricing is limited to one device per merchant. T&C’s apply.
About Square
Square helps sellers more easily run and grow their businesses with its integrated ecosystem of commerce solutions. Square offers purpose-built software to run complex restaurants and retail operations, versatile e-commerce tools, embedded financial services and banking products, an appointment booking platform, staff management and payroll capabilities, and much more – all of which work together to save sellers time and effort. Millions of sellers across the globe trust Square to power their business and help them thrive in the economy. Square is part of Block, Inc. (NYSE: SQ), a global technology company with a focus on financial services. For more information, visit www.squareup.com.
Squareup International Limited, operating under the Square brand name, is an authorised entity subject to the supervision of the Central Bank of Ireland.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220125005134/en/
Contact information
ONA PR
Ana Mohamed | Angy Morales
Square@onapr.es
+34 699 47 17 38
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
